Chronic Nasal Administration of Kisspeptin-54 Regulates Mood-Related Disorders Via Amygdaloid GABA in Hemi-Parkinsonian Rats
Background: Depression and anxiety, the most prevalent neuropsychiatric manifestations in Parkinson’s disease (PD), negatively impact their quality of life. Aims: To determine whether the chronic nasal administration of kisspeptin-54 (KP-54) could. Alleviate symptoms of anxiety and depression in he...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-11-01
|
Series: | Balkan Medical Journal |
Online Access: | https://balkanmedicaljournal.org/text.php?lang=en&id=2643 |